SCHEMBL4338958

SCHEMBL4338958

Nc1cccc2sc(Cl)nc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.56
LMNA P02545 2/20 0.52
PDE10A Q9Y233 1/20 0.52
MAPT P10636 4/20 0.43
TDP1 Q9NUW8 4/20 0.43
GAA P10253 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HPGD P15428 2/20 0.43
PKM P14618 1/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
PDPK1 O15530 1/20 0.43
PSMB8 P28062 1/20 0.40
CYP3A4 P08684 1/20 0.40
KDM4E B2RXH2 3/20 0.38
HIF1A Q16665 1/20 0.38
HSD17B10 Q99714 1/20 0.38
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30066905 1.00 ALDH1A1 (0.56) ALDH1A1LMNAPDE10AMAPTTDP1
SCHEMBL1747928 0.79 LMNA (0.66) ALDH1A1LMNAPDE10AMAPTTDP1
SCHEMBL969167 0.79 ALDH1A1 (0.66) ALDH1A1LMNAPDE10AMAPTTDP1
Hydrochloric Acid SCHEMBL28787382 0.78 ALDH1A1 (0.63) ALDH1A1LMNAPDE10AMAPTTDP1
SCHEMBL3790319 0.78 ALDH1A1 (0.58) ALDH1A1LMNAPDE10AMAPTTDP1
SCHEMBL17987894 0.76 PDPK1 (0.61) ALDH1A1LMNAPDE10AMAPTTDP1
SCHEMBL14127131 0.76 ALDH1A1 (0.61) ALDH1A1LMNAPDE10AMAPTTDP1
SCHEMBL2749466 0.76 ALDH1A1 (0.56) ALDH1A1LMNAPDE10AMAPTTDP1
SCHEMBL2634141 0.76 SMN1; SMN2 (0.61) ALDH1A1LMNAMAPTTDP1GAA
Nitrogen SCHEMBL27703821 0.76 LMNA (0.61) ALDH1A1LMNAPDE10AMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113149979-B 8- (benzothiazole amide) substituted coumarin compound and preparation method and application thereof 朗捷睿(苏州)生物科技有限公司 2022-11-25 CN claimed
WO-2022183961-A1 8-(BENZOTHIAZOLE AMIDE) SUBSTITUTED COUMARIN COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 朗捷睿(苏州)生物科技有限公司 2022-09-09 WO claimed
CN-113149979-A 8- (benzothiazole amide) substituted coumarin compound and preparation method and application thereof 朗捷睿(苏州)生物科技有限公司 2021-07-23 CN claimed
CN-113149979-B 8- (benzothiazole amide) substituted coumarin compound and preparation method and application thereof 朗捷睿(苏州)生物科技有限公司 2022-11-25 CN disclosed
WO-2022183961-A1 8-(BENZOTHIAZOLE AMIDE) SUBSTITUTED COUMARIN COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 朗捷睿(苏州)生物科技有限公司 2022-09-09 WO disclosed
CN-113149979-A 8- (benzothiazole amide) substituted coumarin compound and preparation method and application thereof 朗捷睿(苏州)生物科技有限公司 2021-07-23 CN disclosed
US-20090170913-A1 NOVEL MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170913-A1 NOVEL MCH RECEPTOR ANTAGONISTS MCHR1, MCHR2, MC1R ALDH1A1 1529/4885LMNA 3624/4885PDE10A 1625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.